Genmab reported impressive earnings with significant revenue growth driven by its key products, despite rising expenses.
Hosted on MSN40m
Hybe Posts 18.8% Recorded Music Revenue Slip for Q3 2024, Tees Up Aggressive Q4 Release Schedule, and Eyes 2025 BTS ReunionHybe has revealed rocky Q3 2024 financials, including a nearly 19% YoY slip in recorded music revenue as well as a 98.6% YoY ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback